US Patent Issued to AQUILON PHARMACEUTICALS on Feb. 24 for "Golf ball-like microparticles for use in the treatment and prevention of pulmonary diseases" (Belgian Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,313, issued on Feb. 24, was assigned to AQUILON PHARMACEUTICALS (Vise, Belgium).

"Golf ball-like microparticles for use in the treatment and prevention of pulmonary diseases" was invented by Paul Maes (Vise, Belgium), Didier Cataldo (Olne, Belgium), William Bigazzi (Donceel, Belgium) and Brigitte Evrard (Embourg, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a golf ball-like microparticles obtained by atomization of nanosuspensions of nanoparticles or solutions for dry powder inhalers for use in the treatment and prevention of pulmonary diseases."

The patent was filed on Sept. 10, 2020, under Application No...